Show/Hide

Important Update:
Tempe passed new rules for bike and scooter riders, find out what you need to know here.

Redefining Dementia

Print
Press Enter to show all options, press Tab go to next option

On March 16, 2019, Dementia Friendly Tempe held its fourth annual community summit to help the public understand more about dementia and related disease.  The two speakers who represented the dementia research community were Dr. Eric M. Reiman from the Banner Alzheimer’s Institute and Professor Diego Mastroeni from the ASU-Banner Neurodegenerative Disease Research Center. 

Dr. Reiman and Mayor Mitchell appeared on the Arizona PBS show Horizon to talk about dementia research and the disease's impact to family and community.  Click here to watch the segment.

For attendees who may be interested in more information, we have provided links to their work and research. 

Arizona State University and Banner Alzheimer’s Institute announce research alliance 

Eric M. Reiman, MD: 

Executive Director of the Banner Alzheimer’s Institute, Chief Executive Officer of Banner Research, Professor of Psychiatry at the University of Arizona, University Professor of Neuroscience at Arizona State University, Clinical Director of Neurogenomics at the Translational Genomics Research Institute, and Director of the Arizona Alzheimer’s Consortium.  

Reiman’s research: 

Dr. Reiman’s research interests include brain imaging, genomics, the unusually early detection and tracking of Alzheimer’s disease, and the accelerated evaluation of Alzheimer’s prevention therapies. He is also interested in new models of research collaboration and dementia care. He and his Banner Alzheimer’s Institute colleagues lead the Alzheimer’s Prevention Initiative (API), including prevention trials in cognitively unimpaired persons who, based on their genetic background and age, are at high risk for Alzheimer’s disease, biomarker development and data and sample sharing agreements, unusually large registries to support enrollment in prevention trials, and other efforts to help accelerate the evaluation, approval and availability of prevention therapies.  

Dr. Reiman is an author of more than 400 publications, a principal investigator of several NIH grants, and a recipient of the Potamkin Prize. 

BAI in the media: 

CBS 60 Minutes: The Alzheimer’s Laboratory 

JAMA: Journal of Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study 

Professor Diego Mastroeni:

Assistant Research Professor, ASU-Banner Neurodegenerative Disease Research Center 
Diego Mastroeni's current research is examining genetic changes within the brain regions affected early in Alzheimer's disease and Parkinson's disease. Results could shed new light on the genetic basis of glial dysfunction in dementia. It could also lead to more targeted therapies for Alzheimer's and Parkinson's diseases. 

Mastroeni in the media: 

PBS Catalyst Television Series: Early detection, early treatment 

Thought Huddle Podcast: Alzheimer’s disease: holding on to humanity 

‘Science Exposed’: Performance art meets science in experimental collaboration 

Mastroeni’s Research: 

New findings point to new treatments for Parkinson’s Disease 

Research team to study long term consequences of traumatic brain injury 

New study unveils role of microglial cells, viral linkage in Alzheimer’s and Parkinson’s disease 

ASU-TGen led study identifies source of mutation in Alzheimer’s disease 

Energy storehouses in the brain may be source of Alzheimer’s, targets of new therapy 

Power outage in the brain may be source of Alzheimer’s